Q2 results board meeting postponed and rescheduled to November 5, 2026

Revenue declinedNet loss reportedNegative operating cash flowResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.6%Reaction day

₹110.00

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.4%+2.2% vs market

Pharmaceuticals peers, median of 174sector+0.2%+3.5% vs sector

On the reaction day the stock moved 2.2 pts more than Nifty Microcap 250 and 3.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.6+1.4+2.2+0.2+3.5

Next day

+3.6+1.7+1.9+0.6+3.0

+4.5+3.9+0.6+1.6+2.9

+5.5+5.1+0.4+2.3+3.1

+7.3pendingpending+2.2+5.0

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Starsource Multi Trade Limited informed BSE that the Board meeting to approve un-audited financial results for the quarter ended September 30, 2026, along with the limited review report, has been postponed from November 2 to November 5, 2026 due to unavoidable circumstances. No financial figures were provided.

Likely market impact

Q2 results are expected to be considered on November 5, 2026; the filing provides no financial performance numbers or approval.

By the numbersStandalone · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹0.00 Cr	₹0.53 Cr	−100.0%
Operating profit	−₹0.06 Cr	₹0.10 Cr	−163.6%
Profit after tax	−₹0.06 Cr	₹0.10 Cr	−163.6%
EBITDA margin	—	18.7%	—

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.